These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3560192)

  • 1. A simple one-step hemolytic assay of the first component of human complement (C1) with polyethylene glycol treated human serum: details of the assay procedures and its application to the C1 activation study.
    Nagaki K; Tsuboi M; Matsumoto M; Kitamura H
    J Clin Lab Immunol; 1986 Nov; 21(3):141-6. PubMed ID: 3560192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved method for preparation of C1-depleted serum and its application to hemolytic assay of C1.
    Fukumoto Y; Tsumoto K; Tashiro A; Ohtomo N; Yoshida T
    Complement; 1985; 2(2-3):140-6. PubMed ID: 4085220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stepwise dissociation of subcomponents of C1, the first component of human complement, upon activation on an affinity sorbent].
    Kozlov LV; Shoĭbonov BB; Ivanov AE; Zubov VP; Antonov VK
    Biokhimiia; 1989 Oct; 54(10):1745-51. PubMed ID: 2605275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
    Bianchino AC; Poon PH; Schumaker VN
    J Immunol; 1988 Dec; 141(11):3930-6. PubMed ID: 3183385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
    Doekes G; van Es LA; Daha MR
    J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1.
    Tenner AJ; Frank MM
    J Immunol; 1986 Jul; 137(2):625-30. PubMed ID: 3722818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism.
    Ziccardi RJ
    J Immunol; 1982 Jun; 128(6):2500-4. PubMed ID: 6281332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first component of complement. I. Purification and properties of native C1.
    Medicus RG; Chapuis RM
    J Immunol; 1980 Jul; 125(1):390-5. PubMed ID: 7381205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple one-step procedure for preparation of C1-deficient human serum.
    Neoh SH; Gordon TP; Roberts-Thomson PJ
    J Immunol Methods; 1984 Apr; 69(2):277-80. PubMed ID: 6715891
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
    Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human C1: analysis with Western blotting reveals slow self-activation.
    Hosoi S; Circolo A; Borsos T
    J Immunol; 1987 Sep; 139(5):1602-8. PubMed ID: 3624867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human complement C1 complex has a picomolar dissociation constant at room temperature.
    Tseng Y; Zavodszky P; Schumaker VN
    J Immunol; 1997 Jan; 158(2):937-44. PubMed ID: 8993014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.
    Nilsson T; Bäck O
    Clin Exp Immunol; 1985 Apr; 60(1):178-82. PubMed ID: 3874014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A simplified method for the assessment of C1 esterase inhibitor function].
    Deguchi M; Takemura S; Ueda M; Kasamatsu Y; Yanagida K; Fukuda W; Okamoto M; Onodera H; Sugino S; Kondo M
    Ryumachi; 1990 Jun; 30(3):166-71. PubMed ID: 2244251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous activation of serum C1 in vitro. Role of C1 inhibitor.
    Tseng Y; Poon PH; Zavodszky P; Schumaker VN
    J Immunol; 1991 Sep; 147(6):1884-90. PubMed ID: 1890306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One active C1r subunit is sufficient for the activity of the complement C1 complex: stabilization of C1r in the zymogen form by point mutations.
    Dobó J; Gál P; Szilágyi K; Cseh S; Lörincz Z; Schumaker VN; Závodszky P
    J Immunol; 1999 Jan; 162(2):1108-12. PubMed ID: 9916740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual complement-mediated hemolytic kinetics at low ionic strength.
    Chang NS; Boackle RJ
    Mol Immunol; 1985 Oct; 22(10):1217-24. PubMed ID: 4079941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
    Windfuhr JP; Alsenz J; Loos M
    Mol Immunol; 2005 Apr; 42(6):657-63. PubMed ID: 15781109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.